Caplin Point LAB Ltd.

NSE: CAPLIPOINT · Pharmaceuticals · sector

₹2,273.90NSE close 2026-10-26

Key numbers

Market cap₹17,282 cr

Price₹2,273.90

52w high / low₹2,990 / ₹1,500

P/E26.0xSector median 27.9x

P/B4.8xSector median 2.9x

Book value₹471.9

Dividend yield0.27%Sector median 0.48%

ROE20.7%Sector median 11.7%

ROCE23.5%Sector median 12.3%

OPM34.8%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA20.4xSector median 18.6x

Interest cover959.6x

Current ratio6.70x

Sales growth 3y+14.2%Sector median +9.6%

Profit growth 3y+19.4%Sector median +13.3%

PEG1.34x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹1,007 cr vs borrowings ₹1 cr (FY26): cash is higher (net cash).
Operating profit covered interest 959.6x in the last 12 months.
No promoter shares are pledged.
Operating cash flow was below net profit in 4 of the last 5 years (FY26, FY25, FY24, FY23).
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 19% of net profit in the last 12 months.
Debtor days went from 117 (FY24) to 138 (FY26).
Dividend paid in 5 of the last 5 financial years.
Price ₹2,273.90 on 2026-10-26: -23.9% from the 52-week high, +51.6% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹2,867.40 · low ₹1,560.30

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	483	493	502	510	534	543	600	610
EBITDA	165	162	168	178	189	190	204	213
OPM %	34.1%	32.9%	33.4%	34.8%	35.4%	34.9%	34.0%	35.0%
Other income	21	31	26	23	30	34	28	34
Net profit	131	139	141	153	154	164	170	177
EPS (₹)	17.22	18.28	18.75	20.10	20.32	21.56	22.38	23.27
Revenue YoY					+10.5%	+10.1%	+19.4%	+19.6%
Profit YoY					+18.1%	+17.9%	+20.8%	+15.8%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	1,269	1,467	1,694	1,937	2,187	2,287
EBITDA	395	441	552	647	761	797
Net profit	308	376	457	563	641	665
EPS (₹)	39.61	49.62	60.19	70.57	84.36	87.53
Revenue growth		+15.5%	+15.5%	+14.4%	+12.9%	+15.0%
Profit growth		+22.0%	+21.5%	+23.3%	+13.8%	+18.1%
Dividend / share (₹)	3.00	4.00	4.50	5.00	6.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+14.2%	+15.6%	+15.0%
Net profit	+19.4%	+21.5%	+18.1%
EPS	+19.4%	+21.4%	–
Share price	–	+8.2% (2y)	+9.4%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	1,880	2,316	2,850	3,586
Borrowings	–	3	1	1	1
Cash & equivalents	–	653	791	903	1,007
Total assets	–	2,191	2,697	3,209	4,045
Fixed assets	–	267	439	530	547
Capital work in progress	–	220	117	139	209
Investments	–	71	138	279	473
Receivables	–	394	543	632	826
Inventory	–	288	363	336	429
Payables	–	164	209	218	296

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	337	272	311	432	523
Cash from investing	-271	-218	-313	-335	-582
Cash from financing	-41	-28	-38	-38	-46
Capex	91	194	146	192	248
Free cash flow	246	78	165	241	275

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	20.0%	19.7%	19.8%	17.9%
ROCE %	–	24.0%	24.4%	23.8%	22.4%
Debtor days	–	98	117	119	138
Inventory days	–	159	183	159	181
Payable days	–	90	106	103	125
Cash conversion cycle (days)	–	167	194	175	194
Working capital days	–	320	336	344	367

Shareholding

Holder	% (2026-09-30)
Promoters	70.57%
FIIs	5.73%
DIIs	2.20%
of which Mutual funds	1.64%
of which Insurance	0.08%
Government	0.00%
Public (non-institutions)	21.50%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	70.56%	70.56%	70.56%	70.57%	70.57%	70.57%	70.57%	70.57%

Promoter group	%
P Vijayalakshmi	24.71%
Paarthipan C C	18.64%
Ashok Gorkey Partheeban	11.91%
Partheeban Vivek Siddarth	11.85%
MAY India Property Private Limited	2.79%
First Dimension Holdings Private Limited	0.49%
Kiraviz Properties and Consultancy LLP	0.20%
Visalatchi P	0.00%
Chellappan Poovalambedu Kandasamy	0.00%
Kotteswari B	0.00%
Soundari B	0.00%

Public holders above 1%	%
Investor Education and Protection Fund Authority Ministry of Corporate Affairs	2.81%
UTI Nifty 500 Index Fund	1.38%

1,03,386 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
CAPLIPOINT	₹17,282 cr	26.0x	4.8x	20.7%	23.5%	34.8%	+14.2%	0.27%

All 185 companies in Pharmaceuticals →

Business segments (FY26)

Segment	Revenue	Share	EBIT	Margin
Rest of the World	₹1,734 cr	75.3%	₹631 cr	36.4%
USA	₹453 cr	19.7%	₹56 cr	12.4%
Unallocated	₹116 cr	5.0%	₹116 cr	100.0%

Dividends & corporate actions

Ex-date	Action	Detail
2026-09-18	Dividend	Dividend - Rs 4 Per Share
2026-05-29	Dividend	Interim Dividend - Rs 4 Per Share
2025-09-12	Dividend	Dividend - Rs 3 Per Share
2025-05-30	Dividend	Interim Dividend - Rs 3 Per Share
2024-09-23	Dividend	Dividend - Rs 2.50 Per Share
2024-09-23	Other	Annual General Meeting
2024-05-31	Dividend	Interim Dividend - Rs 2.50 Per Share
2023-09-14	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2023-06-09	Dividend	Interim Dividend - Rs 2 Per Share
2022-09-21	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2022-05-23	Dividend	Interim Dividend - Rs 2 Per Share
2021-09-20	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2021-05-18	Dividend	Interim Dividend - Rs 1.50 Per Share
2020-09-21	Dividend	Annual General Meeting/Dividend - Rs 0.40 Per Share
2020-03-12	Dividend	Interim Dividend - Rs 2.10 Per Share
2019-09-04	Dividend	Annual General Meeting/Dividend - Rs 2.20 Per Share
2018-09-18	Dividend	Annual General Meeting/Dividend- Rs 2 Per Share
2017-09-07	Dividend	Annual General Meeting/Dividend - Rs 1.50 Per Share
2016-10-19	Other	Fv Splt Frm Rs 10 To Rs 2
2016-09-01	Dividend	Annual General Meeting/Dividend - Rs 3.50 Per Share

Documents

Links go to the original files on the exchange website.

About the company

Manufacturing and sale of pharmaceuticals: Pharmaceuticals and finished dose formulation


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	CAPLIPOINT
BSE code	524742
ISIN	INE475E01026
Face value	₹2.0
Incorporated	1990-04-16
Website	www.caplinpoint.net
Plants (India / abroad)	9 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.